arrow - morphine la
teva pharma (new zealand) limited - morphine sulfate pentahydrate 10mg - modified release tablet - 10 mg - active: morphine sulfate pentahydrate 10mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry buff oy-3607 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.
arrow - morphine la
teva pharma (new zealand) limited - morphine sulfate pentahydrate 30mg - modified release tablet - 30 mg - active: morphine sulfate pentahydrate 30mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry violet 0y-6708 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.
arrow - morphine la
teva pharma (new zealand) limited - morphine sulfate pentahydrate 60mg - modified release tablet - 60 mg - active: morphine sulfate pentahydrate 60mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry orange oy-3533 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.
arrow - amitriptyline
teva pharma (new zealand) limited - amitriptyline hydrochloride 25mg; ; ; - film coated tablet - 25 mg - active: amitriptyline hydrochloride 25mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc quinoline yellow titanium dioxide - for the treatment of depression.
sertraline actavis
teva pharma (new zealand) limited - sertraline hydrochloride 111.9mg equivalent to 100 mg sertraline; - film coated tablet - 100 mg - active: sertraline hydrochloride 111.9mg equivalent to 100 mg sertraline excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 sodium starch glycolate titanium dioxide - sertraline actavis is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.
sertraline actavis
teva pharma (new zealand) limited - sertraline hydrochloride 55.95mg equivalent to 50 mg sertraline; - film coated tablet - 50 mg - active: sertraline hydrochloride 55.95mg equivalent to 50 mg sertraline excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 sodium starch glycolate titanium dioxide - sertraline actavis is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.
arrow - etidronate
teva pharma (new zealand) limited - disodium etidronate 200mg - tablet - 200 mg - active: disodium etidronate 200mg excipient: magnesium stearate maize starch microcrystalline cellulose pregelatinised maize starch purified water
arrow - brimonidine
teva pharma (new zealand) limited - brimonidine tartrate 0.2%{relative}; - eye drops, solution - 0.2% w/v - active: brimonidine tartrate 0.2%{relative} excipient: benzalkonium chloride citric acid polyvinyl alcohol sodium chloride sodium citrate sodium hydroxide water for injection - effective for lowering intraocular pressure in patients with ocular hypertension.
arrow - timolol
teva pharma (new zealand) limited - timolol maleate 3.4 mg/ml equivalent to timolol 2.5 mg/ml - eye drops, solution - 0.25% w/v - active: timolol maleate 3.4 mg/ml equivalent to timolol 2.5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection
arrow - timolol
teva pharma (new zealand) limited - timolol maleate 6.8 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 0.5% w/v - active: timolol maleate 6.8 mg/ml equivalent to timolol 5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection